Peter Hegemann honored for pioneering research in optogenetics
Hector Fellow Peter Hegemann was awarded the 2026 Nobel Prize in Medicine alongside Karl Deisseroth and Georg Nagel. The three scientists are being honored for their pioneering discoveries in light-gated ion channels and optogenetics. Hegemann is Professor of Experimental Biophysics at Humboldt-Universität zu Berlin and has been a member of the Hector Fellow Academy since 2015.
Peter Hegemann is one of the pioneers of optogenetics, a technique that combines genetics and light to precisely control the activity of cells, particularly neurons His research on light-sensitive proteins in algae led to the discovery and characterization of channelrhodopsins. These proteins can be introduced into specific cells, enabling the activation or inhibition of those cells with pulses of light. Together with subsequent advances in applying this principle to neurons, his work laid the foundation for optogenetics as a powerful research tool.
Today, optogenetics has transformed neuroscience by enabling researchers to investigate the functions of specific cells and neural circuits with remarkable precision. This technology has opened new possibilities for studying how the brain works and exploring the mechanisms underlying neurological diseases. The Nobel Prize recognizes the far-reaching impact of this fundamental research on modern neuroscience and medicine.
The Nobel Prize award ceremony will take place in Stockholm on December 10, 2026, the anniversary of Alfred Nobel’s death.